EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

Jun Xu, Nicolas J Niklaus, Anna M Schläfli, Igor Tokarchuk, Magali Humbert, Federico La Manna, Bich Vu, David Maul, Ramin Radpour, Marianna Kruithof-de Julio, Inti Zlobec, Jörn Dengjel iD und 2 weitere

Molecular Oncology · 2026-11 · 20 (11) · 2718-2740

DOI: 10.1002/1878-0261.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 26.05.2026. Verfasst von Jun Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Tissue Medicine and Pathology, Division of Experimental Pathology, University of Bern, Switzerland. Hauptthemen laut MEDLINE: Autophagy, Cell Movement, Autophagy-Related Protein-1 Homolog, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UniBE International Fellowship, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cyclin D binding Myb‐like Transcription Factor 1 (DMTF1) is a haploinsufficient tumor suppressor in various tumors. Alternative splicing generates a dominant negative, truncated version of full‐length DMTF1α, named DMTF1β. DMTF1β has so far been described as an oncogene in breast cancer development. However, a clear understanding of how DMTF1β contributes to carcinogenesis remains unknown. Analyzing DMTF1β protein expression in breast cancer cell lines, as well as a highly metastatic prostate cancer cell line, confirmed a positive correlation between DMTF1β expression and tumorigenic potential. Specifically, knocking down DMTF1β in aggressive MDA‐MB‐231 breast and PC3MPRO4 prostate cancer cells significantly reduced wound closure and tissue invasion. β‐specific interactome and RNA‐sequencing studies in DMTF1β overexpressing and knockdown cells, respectively, suggest that DMTF1β expression is associated with the autophagy recycling pathway. Depleting DMTF1β levels in cancer cells significantly decreased autophagic flux. Moreover, inhibiting autophagy led to decreased migration of DMTF1β expressing breast cancer cells. Mechanistically, DMTF1β protein interacts with and stabilizes the key autophagy protein ULK1. In conclusion, we identified a novel function for the alternatively spliced DMTF1 gene product in autophagy‐dependent cancer cell motility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyCell MovementAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsTrans-ActivatorsBreast NeoplasmsProstatic NeoplasmsHumansCell Line, TumorProtein StabilityFemaleGene Expression Regulation, NeoplasticMaleTranscription Factors

Stichwörter der Autor:innen

DMTF1ULK1autophagycell migrationoncogenesplice variant

Substanzen

Autophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsULK1 protein, humanDMTF1 protein, humanTrans-ActivatorsTranscription Factors

Autor:innen und Institutionen

  • Institute of Tissue Medicine and Pathology, Division of Experimental Pathology, University of Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland.
  • Department of Biomedical Research, Division of Urology, University of Bern, Switzerland.
  • Department of Biology, University of Fribourg, Switzerland.
  • Department of Biomedical Research, Division of Tumor immunology, University of Bern, Switzerland.
  • Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

ORCID-Profile: Jörn Dengjel, Mario P Tschan

Förderung

  • UniBE International Fellowship
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • China Scholarship Council
  • Joyce Klein Stock Gift Fund
  • Seattle Children's Research Institute
  • Berne University Research Foundation

Zitieren

APA

Xu, J., Niklaus, N. J., Schläfli, A. M., Tokarchuk, I., Humbert, M., La Manna, F., Vu, B., Maul, D., Radpour, R., Kruithof-de Julio, M., Zlobec, I., Dengjel, J., Torbett, B. E., & Tschan, M. P. (2026). Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization. Molecular Oncology, 20(11), 2718-2740. https://doi.org/10.1002/1878-0261.70275

Vancouver

Xu J, Niklaus NJ, Schläfli AM, Tokarchuk I, Humbert M, La Manna F, et al. Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization. Molecular Oncology. 2026;20(11):2718-2740. doi:10.1002/1878-0261.70275

BibTeX
@article{Xu2026,
  author = {Xu, Jun and Niklaus, Nicolas J and Schläfli, Anna M and Tokarchuk, Igor and Humbert, Magali and La Manna, Federico and Vu, Bich and Maul, David and Radpour, Ramin and Kruithof-de Julio, Marianna and Zlobec, Inti and Dengjel, Jörn and Torbett, Bruce E and Tschan, Mario P},
  title = {Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization},
  journal = {Molecular Oncology},
  year = {2026},
  volume = {20},
  number = {11},
  pages = {2718--2740},
  doi = {10.1002/1878-0261.70275}
}
Kostenlos starten →